stoxline Quote Chart Rank Option Currency Glossary
  
Clover Health Investments, Corp. (CLOV)
0.6311  0.009 (1.51%)    04-18 16:00
Open: 0.6255
High: 0.6488
Volume: 2,845,589
  
Pre. Close: 0.6217
Low: 0.6201
Market Cap: 311(M)
Technical analysis
2024-04-18 5:08:55 PM
Short term     
Mid term     
Targets 6-month :  0.92 1-year :  1.06
Resists First :  0.79 Second :  0.91
Pivot price 0.7
Supports First :  0.61 Second :  0.5
MAs MA(5) :  0.63 MA(20) :  0.73
MA(100) :  0.89 MA(250) :  0.98
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  7.8 D(3) :  7.1
RSI RSI(14): 28.6
52-week High :  1.62 Low :  0.61
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ CLOV ] has closed above bottom band by 14.8%. Bollinger Bands are 56.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 2 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.65 - 0.65 0.65 - 0.66
Low: 0.61 - 0.62 0.62 - 0.62
Close: 0.62 - 0.63 0.63 - 0.64
Company Description

Clover Health Investments, Corp. operates as a medicare advantage insurer in the United States. The company through its Clover Assistant, a software platform that provides preferred provider organization and health maintenance organization health plans for medicare-eligible consumers. It also focuses on non-insurance businesses. Clover Health Investments, Corp. was incorporated in 2014 and is based in Franklin, Tennessee.

Headline News

Tue, 16 Apr 2024
Short Interest in Clover Health Investments, Corp. (NASDAQ:CLOV) Drops By 7.5% - MarketBeat

Tue, 16 Apr 2024
Clover Health Investments, Corp.'s (NASDAQ:CLOV) last week's 13% decline must have disappointed retail investors who have a significant stake - Simply Wall St

Mon, 08 Apr 2024
Meme stock Clover Health Investments receives compliance letter from Nasdaq - Nashville Business Journal - The Business Journals

Mon, 18 Mar 2024
Clover Health director Anna Loengard buys $109956 in stock - Investing.com

Sat, 16 Mar 2024
Clover Health Investments, Corp. (NASDAQ:CLOV) Analysts Are Reducing Their Forecasts For This Year - Simply Wall St

Wed, 13 Mar 2024
Why Clover Health Investments Shares Are Trading Higher By 11%? Here Are Other Stocks Moving In Wednesday's ... - Markets Insider

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Healthcare
Industry:
Medical - Healthcare Plans
Shares Out 406 (M)
Shares Float 375 (M)
Held by Insiders 7.3 (%)
Held by Institutions 24.4 (%)
Shares Short 43,980 (K)
Shares Short P.Month 36,540 (K)
Stock Financials
EPS -0.44
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.58
Profit Margin -10.5 %
Operating Margin -10.4 %
Return on Assets (ttm) -17 %
Return on Equity (ttm) -66.4 %
Qtrly Rev. Growth -44.3 %
Gross Profit (p.s.) 0
Sales Per Share 5.02
EBITDA (p.s.) -0.46
Qtrly Earnings Growth 0 %
Operating Cash Flow -116 (M)
Levered Free Cash Flow 72 (M)
Stock Valuations
PE Ratio -1.44
PEG Ratio -0.2
Price to Book value 1.06
Price to Sales 0.12
Price to Cash Flow -2.21
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android